Celldex Therapeutics, Inc.

NASDAQ: CLDX
$36.42
+$0.74 (+2.1%)
Closing price December 6, 2021
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in late-September and October.
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in October. These catalyst events can make or break these companies.
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Although stocks now are beginning to make a comeback, there are still some that are slowing this recovery and punishing their shareholders.
March 11, 2016: Here are four stocks trading with heavy volume among 16 equities making new 52-week lows in Friday’s session. Celldex Therapeutics Inc. (NASDAQ: CLDX) posted a new 52-week low...
March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post...
March 8, 2016: Here are four stocks trading with heavy volume among 18 equities making new 52-week lows today. Performance Sports Group Ltd. (NYSE: PSG) fell by nearly 66% on Tuesday to post a new...
The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony, Urban Outfitters and Valeant Pharmaceuticals.
March 7, 2016: Here are four stocks trading with heavy volume among 12 equities making new 52-week lows today. Celldex Therapeutics Inc. (NASDAQ: CLDX) posted a new 52-week low on Monday. Shares...
Celldex Therapeutics Inc. (NASDAQ: CLDX) got burned in Monday’s regular trading session and ultimately saw its shares fall by over 50%. The reasoning behind this? The independent Data Safety and...
All these Cowen picks offer compelling values for 2016, and all have backed up enough in price for investors to get an outstanding entry point.
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Friday, September 26, 2014.